These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12572539)

  • 21. Initial low-density lipoprotein response to statin therapy predicts subsequent low-density lipoprotein response to the addition of ezetimibe.
    Ziajka PE; Reis M; Kreul S; King H
    Am J Cardiol; 2004 Mar; 93(6):779-80. PubMed ID: 15019893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ezetimibe (Ezetrol): the statins' partner].
    Ducobu J; Sternon J
    Rev Med Brux; 2004 Oct; 25(5):456-61. PubMed ID: 15584647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ezetimibe in hypercholesterolaemia.
    Farnier M
    Int J Clin Pract; 2002 Oct; 56(8):611-4. PubMed ID: 12425372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carboxy-substituted 2-azetidinones as cholesterol absorption inhibitors.
    Vaccaro WD; Sher R; Davis HR
    Bioorg Med Chem Lett; 1998 Feb; 8(3):319-22. PubMed ID: 9871677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Commentary to the article: Kastelein JJ, Akdim F, Stroes ES, et al.; ENHANCE Investigators. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008; 358: 1431-43 ].
    Michałek A
    Kardiol Pol; 2008 May; 66(5):597-8, discussion 598-9. PubMed ID: 18630396
    [No Abstract]   [Full Text] [Related]  

  • 26. Cholesterol absorption inhibitors in the treatment of hyperlipidemia: clinical outcomes in large clinical trials.
    Kesäniemi A
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():29-30. PubMed ID: 18001318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Type 2 diabetics are high risk patients. Concerning LDL-cholesterol to approach effectively to two sources].
    MMW Fortschr Med; 2005 Nov; 147(44):52-3. PubMed ID: 16302495
    [No Abstract]   [Full Text] [Related]  

  • 28. 2-Azetidinone cholesterol absorption inhibitors: increased potency by substitution of the C-4 phenyl ring.
    Vaccaro WD; Sher R; Davis HR
    Bioorg Med Chem; 1998 Sep; 6(9):1429-37. PubMed ID: 9801814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2-Azetidinones as inhibitors of cholesterol absorption.
    Burnett DA; Caplen MA; Davis HR; Burrier RE; Clader JW
    J Med Chem; 1994 Jun; 37(12):1733-6. PubMed ID: 8021912
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.
    Pearson T; Ballantyne C; Sisk C; Shah A; Veltri E; Maccubbin D
    Am J Cardiol; 2007 Jun; 99(12):1706-1713. PubMed ID: 17560879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simvastatin + ezetimibe: a combination with no proven advantages.
    Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17460829
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug treats two sources of cholesterol.
    Nurse Pract; 2005 Mar; 30(3):70. PubMed ID: 15753829
    [No Abstract]   [Full Text] [Related]  

  • 33. Cholesterol lowering and ezetimibe.
    Drazen JM; Jarcho JA; Morrissey S; Curfman GD
    N Engl J Med; 2008 Apr; 358(14):1507-8. PubMed ID: 18376001
    [No Abstract]   [Full Text] [Related]  

  • 34. Ezetimibe for lowering blood cholesterol.
    Husereau DR
    Issues Emerg Health Technol; 2003 Sep; (49):1-4. PubMed ID: 14533615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An investigative look: selective cholesterol absorption inhibitors--embarking on a new standard of care.
    Stein EA
    Am J Manag Care; 2002 Feb; 8(2 Suppl):S36-9; discussion S45-7. PubMed ID: 11855701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there a problem with ezetimibe or just ENHANCEd hype?
    Whayne TF
    Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
    [No Abstract]   [Full Text] [Related]  

  • 37. Cost-effectiveness of statin monotherapy and combination therapy with ezetimibe.
    Perkerson KA; Gillespie EL; Coleman CI
    Conn Med; 2005 Jan; 69(1):19-22. PubMed ID: 15736370
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials.
    Catapano A; Brady WE; King TR; Palmisano J
    Curr Med Res Opin; 2005 Jul; 21(7):1123-30. PubMed ID: 16004682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ezetimib. A new cholesterol absorption inhibitor].
    Heinzl S
    Med Monatsschr Pharm; 2002 Jul; 25(7):229-32. PubMed ID: 12148235
    [No Abstract]   [Full Text] [Related]  

  • 40. Premature release of data from clinical trials of ezetimibe.
    Califf RM; Harrington RA; Blazing MA
    N Engl J Med; 2009 Aug; 361(7):712-7. PubMed ID: 19675335
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.